Dignio

What Dignio does

Dignio AS, founded in 2012 and headquartered in Oslo, Norway, sells Dignio Connected Care — a CE-marked medical device software platform (MDD 93/42/EEC) that unifies remote patient monitoring, telehealth video consultations, electronic medication dispensing, and clinical data management in a single product. The platform centers on two components: Dignio Prevent, the clinician administration console for managing patients, alerts, and dispenser fleets, and MyDignio, the patient-facing mobile/tablet application. It integrates with over 20 Bluetooth-enabled medical sensors (blood pressure, glucose, pulse oximetry, etc.) and two proprietary medication dispensers — Karie Duo (pouch-based, RFID + camera) and Mobili (cassette-based) — the former via the wholly-owned AceAge Inc. subsidiary acquired in 2022 in Ontario, Canada. Infrastructure runs on AWS Europe (Stockholm for EU/EEA, London for UK) under ISO 27001, ISO 13485, and IEC 62304 compliance.

Dignio monetizes primarily through multi-year enterprise software subscriptions sold to Norwegian and international municipalities, hospitals, and care homes, supplemented by hardware sales of its Karie Duo and Mobili dispensers. GTM is direct enterprise field sales into public procurement processes; no self-serve channel exists. Customer segments are vertically organized: primary care municipalities (200+ Norwegian municipalities, the largest segment), specialist hospitals (Oslo University Hospital, Sykehuset Østfold Kalnes, AHUS, Diakonhjemmet, Martina Hansens), and care homes (Dignio Prevent Go). Pricing is quote-based and not publicly disclosed. The company operates across six countries (Norway, Sweden, Finland, Iceland, Canada, USA) and reports 250+ organizational customers and 40,000+ patients served cumulatively.

In January 2026, Dignio was acquired by Swedish private equity firm Summa Equity through its EUR 2.3bn Fund III to fund international expansion; 2025 contracted ARR reached MNOK 180 (~60%+ YoY growth from MNOK 110) and the company achieved profitability. Management continuity was preserved, with CEO Martin Petter Fredriksen and CFO Andreas Sundby Hall remaining in post. Existing pre-acquisition investors included Monte Rosa Capital, Investinor, Fredriksborg Investor, and Stena Sessan, who had backed a MNOK 85 capital raise in 2020.

Name

Dignio

Legal name

Dignio AS

Website

https://dignio.com

Company type

Private

Founded year

2012

Operating status

Acquired

Headcount range

11–50 employees

Short description

Dignio AS is a Norwegian health tech company that sells a CE-marked, unified remote patient monitoring and electronic medication dispensing platform (Dignio Connected Care) to municipalities, hospitals, and care homes in Norway, Sweden, Finland, Iceland, Canada, and the USA, serving 40,000+ patients across 250+ organizations.

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring / Digital Health Software

NAICS

Health Care and Social Assistance (62)

SIC

Services-Health Services (8000), Surgical & Medical Instruments & Apparatus (3841), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

akta.pro secondary industries

Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

Keywords

• Remote patient monitoring
• Telehealth platform
• Medication dispensing devices
• Digital home care
• Connected care software

Headquarters

HQ city

Kråkerøy

HQ country

Norway

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain, Operations

Revenue model

1. Software Subscription (Dignio Connected Care / Dignio Prevent): Healthcare organizations (municipalities, hospitals, care homes) pay subscription fees for the Dignio Prevent administration platform and associated patient monitoring services. This is the core recurring revenue stream.
2. Medication Dispenser Hardware Sales: Dignio sells medication dispensing hardware (Karie Duo, Mobili) to healthcare providers and municipalities as part of their digital home care solution. Hardware may be bundled with the software subscription or sold separately.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Dignio sells a CE-marked digital connected-care software platform called Dignio Connected Care, which combines remote patient monitoring, telehealth video consultations, automated medication dispensing, and clinical data management in a single integrated solution for healthcare providers. The platform is sold to municipalities, hospitals, and care institutions on a subscription basis and is complemented by proprietary medication dispenser hardware (Karie Duo, Mobili) and integrations with more than 20 Bluetooth-enabled medical measurement devices.

Product overview

Dignio offers a modular connected care platform called Dignio Connected Care, consisting of the Dignio Prevent administration platform for healthcare professionals and the MyDignio patient application. The platform integrates medication dispensers (Karie Duo and Mobili), video consultation capabilities, integrated medical sensors (20+ devices), and remote monitoring tools. Dignio Prevent Go and Dignio Care serve nursing home segments. The solution is CE-marked as a medical device under MDD directive 93/42/EØF and is designed for patients with chronic diseases and other conditions requiring home-based care follow-up.

Differentiator

Problem solved

Functional benefit

Brands

• Dignio Prevent: Clinical management platform for healthcare professionals to manage patients, medication dispensers, and remote monitoring
• MyDignio
• Karie
• Karie Duo
• Mobili
• Dignio Prevent Go
• Dignio Care

Products and services

• Dignio Connected Care (Dignio Prevent platform) CE-marked medical-device software platform (Dignio Prevent) for healthcare professionals to manage remote patient monitoring, medication dispensers, equipment, task lists, severity-prioritized alerts, and clinical decision support across primary and specialist health services. Sold via multi-year enterprise subscription to municipalities, hospitals, and care institutions.
• MyDignio patient app

Quantifiable outcome

• Cost reduction per patient per month for healthcare providers
• +8 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability8 records

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• AceAge Inc. (Acquisition)coreStrategic or Co-development Partner · 9 August 2022Dignio acquired AceAge Inc., a Canadian manufacturer of medication dispensers, to gain control over the full value chain of electronic medication dispensing and strengthen its position as an innovator in health technology. AceAge continues to be based in Ontario, Canada, serving existing and new customers, while Dignio collaborates closely with AceAge management on continued product development.
• Amazon Web Services (AWS) EuropecoreTechnology or IntegrationDignio uses AWS Europe for cloud infrastructure. All customer data is stored on AWS servers in Stockholm (for EU/EØS customers) and London (for UK customers). AWS Europe is certified to ISO 27001, ISO 27017, and ISO 27018, and ensures data is not transferred outside the EØS.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Huma: UK-headquartered RPM and decentralized clinical trials platform serving hospitals, pharma and providers. Comparable to Dignio on the digital outpatient clinic and chronic disease monitoring use cases, and on integrating patient-reported outcomes with clinical workflows.
• Health Recovery Solutions: US-based RPM platform for hospitals and home health agencies, providing tablets, Bluetooth peripherals and clinical dashboards. Closely comparable to Dignio's sensor-integrated monitoring and clinical decision support workflow.
• Luscii: Dutch RPM platform serving hospitals and care organizations with condition-specific remote monitoring pathways (COPD, heart failure, etc.). Comparable to Dignio's hospital segment (Oslo University Hospital, AHUS, Diakonhjemmet) and its disease-specific digital outpatient clinic approach.
• Tunstall Healthcare: UK-based connected care platform offering telehealth, telecare and remote patient monitoring for elderly and chronic disease patients in their homes. Operates a B2B model selling to municipalities and care providers, very similar to Dignio's Norwegian municipal GTM and clinical/home-care use cases.
• Vivify Health (Optum / UnitedHealth Group): RPM platform for hospitals, home health and payers, offering connected care kits, patient engagement and remote monitoring. Now part of Optum — directly competes with Dignio in the integrated RPM + telehealth space, though at much larger scale and predominantly in the US.

Broad incumbents

• Resideo Life Care Solutions: RPM and connected care business (originating from Honeywell) offering remote monitoring, medication management and PERS solutions to care providers and payers. A broader incumbent with overlapping capabilities but a wider, less specialized portfolio than Dignio.
• Philips HealthSuite / Philips Remote Patient Monitoring: Broad incumbent with connected care, RPM and medication management products (including medication dispensers) sold globally to hospitals and health systems. Overlaps with Dignio's offering as part of Philips' much wider portfolio, but not a niche specialist.

Emerging players

• Hero Health: Smart in-home medication dispenser for consumers and care providers with adherence tracking and reminders. Overlaps with Dignio's medication dispenser and remote adherence monitoring offerings, though with a more consumer-leaning GTM.
• MedMinder: US smart pill dispenser and medication adherence solution for patients at home, with cellular-connected dispensers and caregiver notifications. Directly comparable to Dignio's Karie Duo / Mobili medication dispenser hardware line and adherence-monitoring use case.
• Doccla: UK-based virtual ward and RPM provider serving the NHS with end-to-end remote monitoring services. Comparable to Dignio on the integrated clinical service + technology model for hospitals and integrated care systems.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/dignio
• Facebookfacebook.com/Dignio
• Xx.com/dignio

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dignio